Pharma
CellFE, a tech-enabled cell engineering platform, and Plenful, a workflow-automation platform for pharmacy operations, also garnered investment.
The biotechnology company told MobiHealthNews it will continue to work within the digital health space through partnerships linked to its 'evolving R&D and commercial priorities.'
The Japanese manufacturer's new company, established in Delaware, will utilize a cell picking and imaging system to help providers detect and treat diseases.
The partnership grew out of a philosophical alignment between the companies, with each citing the desire to simplify access and pricing.
Data exchange platform Briya and clinical trial-participant management platform Mural Health also secured investments.
Also, MedEasy has raised seed funding to expand its user base in Bangladesh.
The company's computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.
The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with COPD.
Also, Abbott has launched its vertigo support app in India.
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.